EDB-FN-specific aptamer-like peptide (APTEDB; Anygen) containing an additional cysteine residue was dissolved in dimethyl sulfoxide (Sigma-Aldrich), and Mal-PEG2000-DSPE was dissolved in chloroform (Sigma-Aldrich). The conjugation reaction was carried out at an APTEDB:Mal-PEG2000-DSPE molar ratio of 1:2 under inert conditions for 12 h at ambient temperature 16. APTEDB-conjugated PEG2000-DSPE (APTEDB-DSPE) was purified by reversed-phase high-performance liquid chromatography, and the conjugation efficiency was determined using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. To remove unconjugated peptides, dialysis was carried out using a dialysis membrane (Spectrum Chemical, NJ, USA) with a molecular weight cutoff of 3.5 kDa. After 48 h, the conjugate was lyophilized.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.